Genetic and chemical modifiers of a CUG toxicity model in Drosophila.

Non-coding CUG repeat expansions interfere with the activity of human Muscleblind-like (MBNL) proteins contributing to myotonic dystrophy 1 (DM1). To understand this toxic RNA gain-of-function mechanism we developed a Drosophila model expressing 60 pure and 480 interrupted CUG repeats in the context...

Full description

Bibliographic Details
Main Authors: Amparo Garcia-Lopez, Lidon Monferrer, Irma Garcia-Alcover, Marta Vicente-Crespo, M Carmen Alvarez-Abril, Ruben D Artero
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2008-02-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2220037?pdf=render
_version_ 1818310204580691968
author Amparo Garcia-Lopez
Lidon Monferrer
Irma Garcia-Alcover
Marta Vicente-Crespo
M Carmen Alvarez-Abril
Ruben D Artero
author_facet Amparo Garcia-Lopez
Lidon Monferrer
Irma Garcia-Alcover
Marta Vicente-Crespo
M Carmen Alvarez-Abril
Ruben D Artero
author_sort Amparo Garcia-Lopez
collection DOAJ
description Non-coding CUG repeat expansions interfere with the activity of human Muscleblind-like (MBNL) proteins contributing to myotonic dystrophy 1 (DM1). To understand this toxic RNA gain-of-function mechanism we developed a Drosophila model expressing 60 pure and 480 interrupted CUG repeats in the context of a non-translatable RNA. These flies reproduced aspects of the DM1 pathology, most notably nuclear accumulation of CUG transcripts, muscle degeneration, splicing misregulation, and diminished Muscleblind function in vivo. Reduced Muscleblind activity was evident from the sensitivity of CUG-induced phenotypes to a decrease in muscleblind genetic dosage and rescue by MBNL1 expression, and further supported by the co-localization of Muscleblind and CUG repeat RNA in ribonuclear foci. Targeted expression of CUG repeats to the developing eye and brain mushroom bodies was toxic leading to rough eyes and semilethality, respectively. These phenotypes were utilized to identify genetic and chemical modifiers of the CUG-induced toxicity. 15 genetic modifiers of the rough eye phenotype were isolated. These genes identify putative cellular processes unknown to be altered by CUG repeat RNA, and they include mRNA export factor Aly, apoptosis inhibitor Thread, chromatin remodelling factor Nurf-38, and extracellular matrix structural component Viking. Ten chemical compounds suppressed the semilethal phenotype. These compounds significantly improved viability of CUG expressing flies and included non-steroidal anti-inflammatory agents (ketoprofen), muscarinic, cholinergic and histamine receptor inhibitors (orphenadrine), and drugs that can affect sodium and calcium metabolism such as clenbuterol and spironolactone. These findings provide new insights into the DM1 phenotype, and suggest novel candidates for DM1 treatments.
first_indexed 2024-12-13T07:42:21Z
format Article
id doaj.art-b690e444b6344a548e5b9b1958a7383a
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-13T07:42:21Z
publishDate 2008-02-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-b690e444b6344a548e5b9b1958a7383a2022-12-21T23:54:56ZengPublic Library of Science (PLoS)PLoS ONE1932-62032008-02-0132e159510.1371/journal.pone.0001595Genetic and chemical modifiers of a CUG toxicity model in Drosophila.Amparo Garcia-LopezLidon MonferrerIrma Garcia-AlcoverMarta Vicente-CrespoM Carmen Alvarez-AbrilRuben D ArteroNon-coding CUG repeat expansions interfere with the activity of human Muscleblind-like (MBNL) proteins contributing to myotonic dystrophy 1 (DM1). To understand this toxic RNA gain-of-function mechanism we developed a Drosophila model expressing 60 pure and 480 interrupted CUG repeats in the context of a non-translatable RNA. These flies reproduced aspects of the DM1 pathology, most notably nuclear accumulation of CUG transcripts, muscle degeneration, splicing misregulation, and diminished Muscleblind function in vivo. Reduced Muscleblind activity was evident from the sensitivity of CUG-induced phenotypes to a decrease in muscleblind genetic dosage and rescue by MBNL1 expression, and further supported by the co-localization of Muscleblind and CUG repeat RNA in ribonuclear foci. Targeted expression of CUG repeats to the developing eye and brain mushroom bodies was toxic leading to rough eyes and semilethality, respectively. These phenotypes were utilized to identify genetic and chemical modifiers of the CUG-induced toxicity. 15 genetic modifiers of the rough eye phenotype were isolated. These genes identify putative cellular processes unknown to be altered by CUG repeat RNA, and they include mRNA export factor Aly, apoptosis inhibitor Thread, chromatin remodelling factor Nurf-38, and extracellular matrix structural component Viking. Ten chemical compounds suppressed the semilethal phenotype. These compounds significantly improved viability of CUG expressing flies and included non-steroidal anti-inflammatory agents (ketoprofen), muscarinic, cholinergic and histamine receptor inhibitors (orphenadrine), and drugs that can affect sodium and calcium metabolism such as clenbuterol and spironolactone. These findings provide new insights into the DM1 phenotype, and suggest novel candidates for DM1 treatments.http://europepmc.org/articles/PMC2220037?pdf=render
spellingShingle Amparo Garcia-Lopez
Lidon Monferrer
Irma Garcia-Alcover
Marta Vicente-Crespo
M Carmen Alvarez-Abril
Ruben D Artero
Genetic and chemical modifiers of a CUG toxicity model in Drosophila.
PLoS ONE
title Genetic and chemical modifiers of a CUG toxicity model in Drosophila.
title_full Genetic and chemical modifiers of a CUG toxicity model in Drosophila.
title_fullStr Genetic and chemical modifiers of a CUG toxicity model in Drosophila.
title_full_unstemmed Genetic and chemical modifiers of a CUG toxicity model in Drosophila.
title_short Genetic and chemical modifiers of a CUG toxicity model in Drosophila.
title_sort genetic and chemical modifiers of a cug toxicity model in drosophila
url http://europepmc.org/articles/PMC2220037?pdf=render
work_keys_str_mv AT amparogarcialopez geneticandchemicalmodifiersofacugtoxicitymodelindrosophila
AT lidonmonferrer geneticandchemicalmodifiersofacugtoxicitymodelindrosophila
AT irmagarciaalcover geneticandchemicalmodifiersofacugtoxicitymodelindrosophila
AT martavicentecrespo geneticandchemicalmodifiersofacugtoxicitymodelindrosophila
AT mcarmenalvarezabril geneticandchemicalmodifiersofacugtoxicitymodelindrosophila
AT rubendartero geneticandchemicalmodifiersofacugtoxicitymodelindrosophila